// App-Quantinova.ai

: Analysis of US Claims Real World Data of Hemophilia a & B Patients: Units Dispensed & Expenditures Associated with Utilization of and Switching from Standard to Extended Half-Life Factor Products

Researchers

Presenter

  • Bartholomew J. Tortella

Principal Investigators

  • Amit Chhabra

  • Jos Alvir

  • Emily R. Rubinstein

  • Lisa J. Young

  • Patrick F. Fogarty

Medical Centers

  • Pfizer Inc, Collegeville, PA

  • Pfizer Inc, New York, NY

  • Pfizer Inc, New York, NY

  • Pfizer Inc, New York, NY

  • Pfizer Inc., Walton Oaks, United Kingdom

  • Pfizer Inc, Collegeville, PA

Locations

  • United States

  • United Kingdom

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved